e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Pulmonary vascular biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary artery endothelial cell secretion of factor VIII
C. Shovlin, G. Angus, R. Manning, M. Laffan, G. Birdsey, F. Mauri (London, United Kingdom)
Source:
Annual Congress 2008 - Pulmonary vascular biology
Session:
Pulmonary vascular biology
Session type:
Thematic Poster Session
Number:
998
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Shovlin, G. Angus, R. Manning, M. Laffan, G. Birdsey, F. Mauri (London, United Kingdom). Pulmonary artery endothelial cell secretion of factor VIII. Eur Respir J 2008; 32: Suppl. 52, 998
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Congenital airway diseases
Should we screen for hereditary pulmonary hypertension?
Related content which might interest you:
Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 545s
Year: 2006
Cell freehaemoglobin and pulmonary artery endothelial cell dysfunction
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Vascular endothelial growth factor levels in active pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 610s
Year: 2002
Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002
Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Nerve growth factor expression and function in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Imbalance between vascular endothelial growth factor and endostatin in emphysema
Source: Eur Respir J 2003 Oct 01;22(4):609-612
Year: 2003
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion.
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma
Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma
Year: 2004
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
MicroRNA-155 controls pulmonary artery fibroblast cell signalling and proliferation in a knockout mouse model: A role in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006
The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
Source: Eur Respir J 2007; 29: 1094-1104
Year: 2007
Vascular endothelial growth factor (VEGF) and CD31 expression in experimental prosthetic tracheal replacement
Source: Annual Congress 2009 - Current challenges in thoracic surgery
Year: 2009
Hyperoxia-induced gene expression and apoptosis of human pulmonary artery endothelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 397s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept